Actionable news
0
All posts from Actionable news
Actionable news in JNP: JUNIPER PHARMACEUTICALS Inc COMMON STOCK,

BRIEF-Juniper Pharma says discontinuing development of COL-1077, based on results of Phase 2B trial

Aug 17 Juniper Pharmaceuticals Inc

* "we are disappointed that col-1077 did not achieve desired effect in this clinical trial"

* Based on results of phase 2b trial, discontinuing development of...


More